Neuro Notes

 
 
  • CGRP Receptor Antagonists for Migraine Prevention: What's New   Drs Andrew Wilner and David Dodick discuss CGRP receptor antagonists and a recent abstract presented at the 2022 American Academy of Neurology meeting.
  • Antiseizure Drugs Associated With Movement Disorders   New findings are linking certain antiseizure medications to movement disorders in patients with epilepsy.
  • Skin Testing May Help Detect Movement Disorders   Drs Andrew Wilner and Christopher Gibbons discuss recent data on alpha-synuclein in the context of synucleinopathies presented at the 2022 American Academy of Neurology meeting.
  • Smartphone Diagnosis in Infant Seizures: Highly Effective?   Drs Andrew Wilner and Chethan Rao discuss the potential use for smartphone video as an important adjunct in the diagnosis and treatment of infantile spasms.
  • What's Wrong With EEG Interpretation   Dr Andrew Wilner speaks with epilepsy expert Dr Selim Benbadis about how EEG overinterpretation undercuts epilepsy management.
  • Antiseizure Meds and Cardiovascular Risk   Dr Andrew Wilner speaks with researcher Dr Colin Josephson about how big data is revealing the ways that certain epilepsy treatments elevate risks.
  • A Rare Case of Status Epilepticus in a Patient Prescribed CBD   Dr Andrew Wilner speaks with an investigator who encountered a surprising complication after transitioning a patient with intractable focal epilepsy to CBD adjunctive therapy.
  • A Game-Changing Trial Offers New Hope for ALS   Dr Andrew Wilner speaks with Dr Sabrina Paganoni about the CENTAUR trial, whose results made a big splash at the recent AAN annual meeting.
  • Filming Seizures -- A HIPAA Violation? Capturing a patient's seizure on video can be invaluable in making an accurate diagnosis. But patient privacy laws often get in the way.
  • Some 'Novel' Surprises in Epilepsy Data   Epilepsy expert Dr Joseph Sirven shares his highlights from this year's AAN annual meeting with Dr Andrew Wilner.
  • How HIPAA Can Harm Patients As Dr Andrew Wilner has experienced first-hand, HIPAA may not always be in the patient's best interest.
  • New Guidance on Identifying Brain Death   Dr Andrew Wilner interviews Dr Gene Sung, lead author of the new guidelines from the World Brain Death Project.
  • Could RAS Dysfunction Explain COVID's Effects? Dr Andrew Wilner speaks with the researcher proposing that the renin-angiotensin system is the reason for COVID-19's complex symptoms.
  • How a Medical School Dean Got Ahead of COVID-19   Dr Andrew Wilner talks with Dr Scott Strome, executive dean and vice chancellor for Clinical Affairs at University of Tennessee Health Science Center.
  • Why Are Cases of SUDEP Declining?   Dr Andrew Wilner speaks with Dr Daniel Friedman about how expanded coverage and increased awareness may be reducing sudden unexplained death in epilepsy.
  • Talking Through Pandemic Anxiety With a Pioneer of Mind-Body Medicine   Dr Andrew Wilner speaks with Dr James Gordon about drawing on his decades of experience to stay mentally and physically healthy in a year of unprecedented challenges.
  • Understanding the Puzzling Pathology of COVID-19   Drs Andrew Wilner and William Li discuss recent findings suggesting that many of the symptoms of SARS-CoV-2 -- stroke included -- may be due to underlying vascular pathology.
  • How COVID-19 Affects the Brain As of now, there is no convincing evidence that the virus directly affects the central or peripheral nervous system, says Dr Andrew Wilner.
  • A Neurologist Over 60 Looks at COVID-19 Dr Andrew Wilner on how he and his county hospital have adapted to the coronavirus pandemic.
  • Maybe Memorizing the Krebs Cycle Was Worthwhile After All Mitochondrial disorders are often difficult to diagnose and treat due to their multisystem nature. As scientists better understand mitochondrial function, effective treatments are beginning to emerge.